Castle Biosciences, Inc.CSTLNASDAQ
LOADING
|||
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | -6.16% |
| Q2 2025 | -4.25% |
| Q1 2025 | 2.11% |
| Q4 2024 | -0.06% |
| Q3 2024 | -3.19% |
| Q2 2024 | 22.69% |
| Q1 2024 | 10.02% |
| Q4 2023 | 7.02% |
| Q3 2023 | 28.39% |
| Q2 2023 | 22.68% |
| Q1 2023 | 10.54% |
| Q4 2022 | 2.37% |
| Q3 2022 | 3.68% |
| Q2 2022 | 29.86% |
| Q1 2022 | 2.28% |
| Q4 2021 | 7.73% |
| Q3 2021 | -0.45% |
| Q2 2021 | -3.66% |
| Q1 2021 | 35.27% |
| Q4 2020 | 14.79% |
| Q3 2020 | 20.56% |
| Q2 2020 | -29.67% |
| Q1 2020 | -3.82% |
| Q4 2019 | 19.58% |
| Q3 2019 | 49.40% |
| Q2 2019 | 22.85% |
| Q1 2019 | -29.30% |
| Q4 2018 | 326.51% |
| Q3 2018 | -10.99% |
| Q2 2018 | 10.27% |
| Q1 2018 | 0.00% |